Protocols for High-Risk Pregnancies, 7th Edition: Snapshot: Protocol 18 - Peripartum Cardiomyopathy

Publication
Article
Contemporary OB/GYN JournalVol 66 No 1
Volume Vol 66
Issue No 1

Snapshot: Protocol 18 - Peripartum Cardiomyopathy

AUTHORS: Sarah Rae Easter, MD, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Division of Critical Care Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, and Carolyn M. Zelop, MD, Director of Ultrasound, Fetal Echocardiography and Perinatal Research, The Valley Hospital, Ridgewood, NJ, and Clinical Professor of Ob/Gyn, NYU School of Medicine, New York, New York.

SYNOPSIS: In this protocol, Easter and Zelop review the clinical presentation and diagnosis of peripartum cardiomyopathy, the pathogenesis of peripartum and other cardiomyopathies, and stabilization and treatment. Included is information on immediate management of peripartum cardiomyopathy, considerations for location and timing of delivery, perspective on chronic therapy and long-term follow-up, and pearls for the obstetric care provider.

Key Messages:

  • Crackles or rales, systolic or diastolic murmur, or extra heart sounds such as an S3 or S4 should heighten concern for peripartum cardiomyopathy. Evaluation includes chest x-ray and an electrocardiogram. Abnormal results, or normal results on either plus an atypical history or physical exam, warrant further investigation.
  • The clinical presentation of peripartum cardiomyopathy is most often that of decompensated left-sided heart failure but right-sided dysfunction also can be present.
  • Common risk factors for peripartum cardiomyopathy are maternal age > 30 years, African descent, multiple gestation, and history of hypertension or preeclampsia.
  • Immediate management of peripartum cardiomyopathy is focused on optimization of preload, typically with diuretics, afterload reduction, and supportive care. Cardiac telemetry, continuous fetal monitoring, and close urine output monitoring with placement of a urethral catheter are warranted.
  • Delivery is recommended for patients with unstable peripartum cardiomyopathy but timing depends on the gestational age of the fetus. An attempted vaginal delivery is recommended for patients without an obstetric contraindication with consideration of cesarean delivery for causes of acute decompensated heart failure.
  • With medical therapy (i.e. beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and diuretics) 50% to 80% of women with peripartum cardiomyopathy ultimately recover to an ejection fraction > 50% at 6 months. Those with a left ventricular ejection fracture < 50% should be advised against pregnancy.

Watch an interview with Queenan and Spong here.

Read the full chapter here.

Recent Videos
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
March of Dimes reports increase in maternity care desert prevalence | Image Credit: marchofdimes.org.
Discussing low-dose aspirin use for preeclampsia prevention | Image Credit: komodohealth.com
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
The impact of smoking cessation on pregnancy outcomes | Image Credit: rwjmg.rwjms.rutgers.edu
Maximizing maternal health: The impact of exercise during pregnancy | Image Credit: cedars-sinai.org
Related Content
© 2024 MJH Life Sciences

All rights reserved.